Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes

Journal of Clinical Pharmacology

Volumn 51, Issue 2, 2011, Pages 153-164

  Jauslin, Petra M ^a,b   Frey, Nicolas ^b   Karlsson, Mats O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b F Hoffmann La Roche ^*  (Switzerland)

Author keywords

circadian rhythm; glucose homeostasis; meal test; NONMEM; type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; PLACEBO;

ADULT; ARTICLE; CIRCADIAN RHYTHM; DIABETIC PATIENT; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; REGULATORY MECHANISM;

BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS;

EID: 79551698982     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010362536     Document Type: Article

References (46)

1. Marshall S., Macintyre F., James I., Krams M., Jonsson NE Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development: a case study of a therapeutic protein. Clin Pharmacokinet. 2006 ; 45: 177-197.
2. Jonsson EN, Macintyre F., James I., Krams M., Marshall S. Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition. Pharm Res. 2005 ; 22: 1236-1246.
3. Silber HE, Jauslin PM, Frey N., Gieschke R., Simonsson US, Karlsson MO An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations. J Clin Pharmacol. 2007 ; 47: 1159-1171.
4. Jauslin P., Silber HE, Frey N., et al. An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics. J Clin Pharmacol. 2007 ; 47: 1244-1255.
5. Boden G., Chen X., Urbain JL Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes. 1996 ; 45: 1044-1050.
6. Shapiro ET, Polonsky KS, Copinschi G., et al. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab. 1991 ; 72: 444-454.
7. Yki-Jarvinen H., Helve E., Sane T., Nurjhan N., Taskinen MR Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol. 1989 ; 256: E732 - E739.
8. Beebe CA, Van Cauter E., Shapiro ET, et al. Effect of temporal distribution of calories on diurnal patterns of glucose levels and insulin secretion in NIDDM. Diabetes Care. 1990 ; 13: 748-755.
9. Carroll MF, Schade DS The dawn phenomenon revisited: implications for diabetes therapy. Endocr Pract. 2005 ; 11: 55-64.
10. Bergman R., Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979 ; 236: E667 - E677.
11. Cobelli C., Toffolo G., Ferrannini E. A model of glucose kinetics and their control by insulin: compartmental and noncompartmental approaches. Math Biosci. 1984 ; 72: 291-315.
12. Caumo A., Cobelli C. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol. 1993 ; 264: E829 - E841.
13. Vicini P., Caumo A., Cobelli C. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol. 1997 ; 273: E1024 - E1032.
14. De Gaetano A., Arino O. Mathematical modelling of the intravenous glucose tolerance test. J Math Biol. 2000 ; 40: 136-168.
15. Mari A., Schmitz O., Gastaldelli A., Oestergaard T., Nyholm B., Ferrannini E. Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002 ; 283: E1159 - E1166.
16. Mari A., Camastra S., Toschi E., et al. A model for glucose control of insulin secretion during 24 h of free living. Diabetes. 2001 ; 50: 164-168.
17. Toschi E., Camastra S., Mari A., et al. A model for assessing insulin secretion and its control under free-living conditions. Diabetes. 2001 ; 50: S178 - S179.
18. Salinari S., Bertuzzi A., Manco M., Mingrone G. NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test. Am J Physiol Endocrinol Metab. 2007 ; 292: E1890 - E1898.
19. Dyck P., Davies JL, Clark VM, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006 ; 29: 2282-2288.
20. Guillausseau P. Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination. Diabet Med. 1997 ; 14: 798-802.
21. Twomey PJ Plasma glucose measurement with the Yellow Springs Glucose 2300 STAT and the Olympus AU640. J Clin Pathol. 2004 ; 57: 752-754.
22. Savic R., Jonker DM, Kerbusch T., Karlsson MO Evaluation of a transit compartment model versus a lag time model for describing drug absorption delay: Population Approach Group Europe (PAGE) 13, published 2004. http://www.page- meeting.org/?abstract=513. Accessed February 16, 2010.
23. Carroll KF, Nestel PJ Diurnal variation in glucose tolerance and in insulin secretion in man. Diabetes. 1973 ; 22: 333-348.
24. Verrillo A., De Teresa A., Martino C., et al. Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. Am J Physiol. 1989 ; 257: E459 - E465.
25. Lee A., Ader M., Bray GA, Bergman RN Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes. 1992 ; 41: 742-749.
26. Shih KC, Ho LT, Kou HF, et al. Diurnal variation of insulin sensitivity in NIDDM patients and normal subjects. J Formos Med Assoc. 1992 ; 91: 263-269.
27. Wu MS, Ho LT, Jap TS, Chen JJ, Kwok CF Diurnal variation of insulin clearance and sensitivity in normal man. Proc Natl Sci Counc Repub China B. 1986 ; 10: 64-69.
28. Van Cauter E., Blackman JD, Roland D., Spire JP, Refetoff S., Polonsky KS Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991 ; 88: 934-942.
29. Hempel G., Karlsson MO, de Alwis DP, Toublanc N., McNay J., Schaefer HG Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements. Clin Pharmacol Ther. 1998 ; 64: 622-635.
30. Nagaraja NV, Pechstein B., Erb K., et al. Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women. Clin Pharmacol Ther. 2000 ; 68: 617-625.
31. Lönnebo A., Grahnén A., Karlsson MO An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers. Br J Clin Pharmacol. 2007 ; 64: 125-132.
32. Beal S., Sheiner LB NONMEM Users Guide (I-VIII). Hanover, Md: GloboMax LLC ; 1989-1998.
33. Yano Y., Beal SL, Sheiner LB Evaluating pharmacokinetic/ pharmacodynamic models using the posterior predictive check. J Pharmacokin Pharmacodyn. 2001 ; 28: 171-192.
34. Caumo A., Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab. 2000 ; 85: 4396-4402.
35. Steil GM, Hwu CM, Janowski R., et al. Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. Diabetes. 2004 ; 53: 1201-1127.
36. Taylor R., Magnusson I., Rothman DL, et al. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest. 1996 ; 97: 126-132.
37. Ludvik B., Nolan JJ, Roberts A., et al. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest. 1997 ; 100: 2354-2361.
38. Livesey G., Wilson PD, Dainty JR, et al. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol. 1998 ; 275: E717 - E728.
39. Fery F., Tappy L., Deviere J., Balasse EO Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans. Am J Physiol Endocrinol Metab. 2004 ; 286: E176 - E183.
40. Vella A., Shah P., Basu R., et al. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 ; 283: E259 - E266.
41. Hooker AC, Staatz CE, Karlsson MO Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method. Pharm Res. 2007 ; 24: 2187-2197.
42. Van Cauter E., Polonsky KS, Scheen AJ Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997 ; 18: 716-738.
43. Garvey WT, Olefsky JM, Rubenstein AH, Kolterman OG Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM: correlation with urinary C-peptide excretion. Diabetes. 1988 ; 37: 590-599.
44. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 ; 318: 1231-1239.
45. Havlin CE, Cryer PE Nocturnal hypoglycemia does not commonly result in major morning hyperglycemia in patients with diabetes mellitus. Diabetes Care. 1987 ; 10: 141-147.
46. Radziuk J., Pye S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes: suprachiasmatic deficit or limit cycle behaviour ? Diabetologia. 2006 ; 49: 1619-1628.